Ipamorelin
Ghrelin receptor agonist studied for growth hormone release.
Search names: IP, Ipa, Ipamorelin(IP/Ipa)
Evidence
Catalogue entry · see sources
Describes the linked sources, not an overall score for product quality or effectiveness.Half-life
Statistics reference: About 2 hours
Human information in catalogueContext and sources for the statistics reference
Intravenous study in healthy men; not a measurement after subcutaneous administration.
About 2 hours · Catalogue information from PeptideTracker.ai; read the limitation above. PeptideTracker.ai · Ipamorelin ↗
Half-life, duration of effect and shelf life are different measures. Catalogue values may differ between variants and administration routes. Curves continue to use their stated statistics reference.
Adverse effects and limitations
The regulatory source below describes safety concerns or data gaps. Administration route and product identity matter.
Sources and further reading
Vital · user-supplied screen recordings, 1 Nov 2026
Regulatory sourceFDA · substance-specific safety information↗Find researchPubMed · Ipamorelin↗Research information, not a personal dosing plan. Last reviewed: 2026-11-01.